Imescia Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Liquidation

Imescia General Information

Description

Developer of an innovative subcutaneous formulation designed for anticancer potent API designed to unlock the full potential of anti-cancer drugs. The company leverages its unique technology that allows an increased tumor accumulation of HPAPIs which enhances their efficacy with the help of a prodrug polymer approach, enabling cancer patients to get quality treatments.

Contact Information

Website
www.imescia.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 5, rue Jean-Baptiste Clement
  • 92290 Chatenay-Malabry
  • France
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 5, rue Jean-Baptiste Clement
  • 92290 Chatenay-Malabry
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Imescia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 22-Nov-2024 Completed Bankruptcy: Liquidation
5. Accelerator/Incubator 09-Feb-2022 Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Seed Round 03-Jun-2021 Completed Pre-Clinical Trials
2. Accelerator/Incubator 31-Mar-2020 Completed Pre-Clinical Trials
1. Grant 09-Jul-2019 $56.5K Completed Startup
To view Imescia’s complete valuation and funding history, request access »

Imescia Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Imescia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022263627-A1 Polymer derivatives of mertansine and therapeutic uses thereof Inactive 18-Jun-2021

Imescia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Imescia FAQs

  • When was Imescia founded?

    Imescia was founded in 2019.

  • Where is Imescia headquartered?

    Imescia is headquartered in Chatenay-Malabry, France.

  • What is the size of Imescia?

    Imescia has 4 total employees.

  • What industry is Imescia in?

    Imescia’s primary industry is Biotechnology.

  • Is Imescia a private or public company?

    Imescia is a Private company.

  • What is Imescia’s current revenue?

    The current revenue for Imescia is .

  • How much funding has Imescia raised over time?

    Imescia has raised $1.22M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process